Prelude Capital Management’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-430	Closed	-$112K	–	1854
2018 Q4	$112K	Buy	+430	New	+$112K	0.01%	651
2018 Q3	–	Sell	-469	Closed	-$111K	–	1761
2018 Q2	$111K	Buy	+469	New	+$111K	0.01%	700